News
06-21-2022, 11:43 AM
New research in the June 2022 issue of JNCCN-;Journal of the National Comprehensive Cancer Network raises issues with clinical trial findings that show adjuvant hormone therapy (AHT)-related hot flashes predict better outcomes for estrogen receptor-positive (ER+) breast cancer.
More... (https://www.news-medical.net/news/20220621/Breast-cancer-trial-results-may-not-translate-to-real-world-outcomes-based-on-treatment-discontinuation.aspx)
More... (https://www.news-medical.net/news/20220621/Breast-cancer-trial-results-may-not-translate-to-real-world-outcomes-based-on-treatment-discontinuation.aspx)